We are live on ! Find out more
FWP

Forward Pharma A/S American Depositary Shares

Delisted

FWP was delisted on the 27th of December, 2022.

7 hedge funds and large institutions have $2.69M invested in Forward Pharma A/S American Depositary Shares in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

17% more funds holding

Funds holding: 67 (+1)

34% less capital invested

Capital invested by funds: $4.04M → $2.69M (-$1.36M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$73.1K
2
Renaissance Technologies
Renaissance Technologies
New York
-$65K
Name Holding Trade Value Shares
Change
Change in
Stake
BI
1
BVF Inc
California
$1.52M
Morgan Stanley
2
Morgan Stanley
New York
$483K -$73.1K -19,300 -11%
MCM
3
Mason Capital Management
New York
$445K
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$181K
PWM
5
Perigon Wealth Management
California
$54K +$68.6K +18,124 New
UBS Group
6
UBS Group
Switzerland
$6K +$8.17K +2,157 New
Renaissance Technologies
7
Renaissance Technologies
New York
-$65K -14,500 Closed

FWP Hedge Fund Activity: Q3 2022 in Review

7 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q3 2022, worth a combined $2.69M — down 34% from $4.04M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new FWP positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Perigon Wealth Management, opening a new position worth an estimated $68.6K. The largest seller was Morgan Stanley, cutting an estimated $73.1K.

  • 7 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q3 2022, up from 6 in Q2 2022.
  • Funds reported $2.69M of Forward Pharma A/S American Depositary Shares stock for Q3 2022, down 34% quarter-over-quarter.
  • 2 funds opened new Forward Pharma A/S American Depositary Shares positions in Q3 2022 and 1 closed out, a net change of +1 holder.
  • The largest Forward Pharma A/S American Depositary Shares buyer in Q3 2022 was Perigon Wealth Management, an estimated $68.6K added.
  • The largest Forward Pharma A/S American Depositary Shares seller in Q3 2022 was Morgan Stanley, an estimated $73.1K sold.

Based on aggregated 13F filings for Q3 2022.